Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Plasma Fractionation Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
5.1.1.2. Government initiatives to increase plasma collection
5.1.1.3. Growing prevalence of elderly people around the globe and the increasing number of blood collection facilities
5.1.2. Restraints
5.1.2.1. Presence of new pathogenic agents that resist the present viral inactivation treatments
5.1.3. Opportunities
5.1.3.1. Continuous advancements in process development technology for improved formulations
5.1.3.2. Exponential utilization in new clinical trials and growing R&D activities in plasma treatment
5.1.4. Challenges
5.1.4.1. Stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies
5.2. Market Segmentation Analysis
5.2.1. Product: Rising use of plasma fractionation for immunoglobulins purification
5.2.2. Application: Proliferating use to treat hematological disorders
5.2.3. End-User: Extensive use of plasma fractionation in clinical research laboratories to ensure the safety and efficacy of plasma-derived products
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Plasma Fractionation Market, by Product
6.1. Introduction
6.2. Albumin
6.3. Coagulation Factor Concentrates
6.4.1. Factor IX
6.4.2. Factor VIII
6.4.3. Factor XIII
6.4.4. Fibrinogen Concentrates
6.4.5. Prothrombin Complex Concentrate
6.4.6. Von Willebrand Factor
6.4. Immunoglobulin
6.5.1. Intravenous Immunoglobulin
6.5.2. Subcutaneous Immunoglobulin
6.5. Protease Inhibitors

7. Plasma Fractionation Market, by Application
7.1. Introduction
7.2. Critical Care
7.3. Hemato-Oncology
7.4. Hematology
7.5. Neurology
7.6. Pulmonology
7.7. Rheumatology

8. Plasma Fractionation Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Clinical Research Laboratories

9. Americas Plasma Fractionation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Plasma Fractionation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Plasma Fractionation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations
12.3.2. New Product Launch & Enhancement
12.3.2.1. Kedrion presented at plasma fractionation workshop in Saudi Arabia
12.3.3. Award, Recognition, & Expansion
12.3.3.1. CSL’s USD470 Million Plasma Fractionation Facility Opens in Marburg, Germany
12.3.3.2. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. ADMA Biologics, Inc.
13.1.3. Bharat Serums and Vaccines Limited
13.1.4. Bio Products Laboratory Ltd.
13.1.5. Biotest AG by Grifols, S.A.
13.1.6. China Biologic Products, Inc.
13.1.7. CSL Limited
13.1.8. Emergent BioSolutions Inc.
13.1.9. Fusion Health Care Pvt. Ltd.
13.1.10. GC Biopharma corp.
13.1.11. Grifols, S.A.
13.1.12. HEINKEL Process Technology GmbH
13.1.13. Hemarus Therapeutics Ltd
13.1.14. Intas Pharmaceuticals Ltd.
13.1.15. Kamada Ltd.
13.1.16. Kedrion S.p.A.
13.1.17. LFB SA
13.1.18. Merck KGaA
13.1.19. Octapharma AG
13.1.20. PlasmaGen BioSciences Pvt. Ltd.
13.1.21. Prothya Biosolutions B.V.
13.1.22. Sanquin
13.1.23. Shanghai Raas Blood Products Co. Ltd
13.1.24. SK Plasma Co.,Ltd.
13.1.25. STERIS plc
13.1.26. Takeda Pharmaceutical Company Ltd
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. PLASMA FRACTIONATION MARKET SIZE, 2023 VS 2030
FIGURE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PLASMA FRACTIONATION MARKET DYNAMICS
FIGURE 7. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 9. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 17. PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 48. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 49. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 75. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 76. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 80. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 81. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 90. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 91. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 120. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 121. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 136. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 137. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 146. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 147. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 157. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 166. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 167. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 181. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 182. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. POLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. POLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 186. POLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 187. POLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. QATAR PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 191. QATAR PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 192. QATAR PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 240. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. PLASMA FRACTIONATION MARKET LICENSE & PRICING